Rhind V, Downie W W, Bird H A, Wright V, Engler C
Rheumatol Rehabil. 1982 Feb;21(1):51-3. doi: 10.1093/rheumatology/21.1.51.
Forty-one patients with periarthritis of the shoulder were entered into a double-blind, parallel comparison of naproxen and indomethacin. Both drugs were given twice daily, naproxen 250 mg in the morning and 500 mg at night and indomethacin 50 mg b.d. Twenty patients received naproxen and 21 received indomethacin. Patients were treated for four weeks. Both drugs significantly reduced pain and patients subjective impression of shoulder restriction, but had little significant effect on objective measurements of mobility. Fourteen patients from the naproxen group and 16 patients from the indomethacin group reported side-effects, the most common being nausea and headache. Three patients stopped naproxen and five patients stopped indomethacin because of side-effects. In conclusion, both drugs were equally effective in treating the pain of periarthritis of the shoulder but did little to change the partial loss of movement associated with the disorder.
41例肩周炎患者参与了萘普生和吲哚美辛的双盲平行对照试验。两种药物均每日服用两次,萘普生早晨服用250毫克,晚上服用500毫克,吲哚美辛每日两次,每次50毫克。20例患者服用萘普生,21例患者服用吲哚美辛。患者接受治疗四周。两种药物均显著减轻了疼痛以及患者对肩部活动受限的主观感受,但对活动度的客观测量几乎没有显著影响。萘普生组有14例患者、吲哚美辛组有16例患者报告了副作用,最常见的是恶心和头痛。3例患者因副作用停用萘普生,5例患者因副作用停用吲哚美辛。总之,两种药物在治疗肩周炎疼痛方面同样有效,但对该疾病相关的部分活动丧失几乎没有改善作用。